MAT2A-IN-6

• UNSPSC Description:

  MAT2A-IN-6 is a potent inhibitor of MAT2A. The expression level of MAT2A is abnormally elevated in several types of tumors, including gastric, colon, liver and pancreatic cancers. MAT2A-IN-6 reduces the proliferative activity of MTAP-deficient cancer cells. MAT2A-IN-6 has the potential for the potential for the research of cancer diseases (extracted from patent WO2021254529A1, compound 18)[1].

• Target Antigen:

  Methionine Adenosyltransferase (MAT)

• Type:

  Reference compound

• Related Pathways:

  Epigenetics;Metabolic Enzyme/Protease

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/mat2a-in-6.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(C1=C(NC)C2=C(N(C3=CC=CC=C3Cl)C1=O)N=C(C(F)(F)F)C=C2)OC

• Molecular Weight:

  411.76

• References & Citations:

  [1]Li Zhen, et al. Bicyclic compounds. Patent WO2021254529A1.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2756458-72-5